Mölndal, Sweden

Petra Johannesson

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Molndal, SE (2017)
  • Mölndal, SE (2011 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Petra Johannesson: Innovator in Cardiovascular Therapy

Introduction

Petra Johannesson is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cardiovascular disorders. With a total of 6 patents to her name, her work is recognized for its potential therapeutic applications.

Latest Patents

One of her latest patents involves the development of 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase (MPO). This patent discloses certain compounds of formula (I) and their pharmaceutically acceptable salts, along with compositions containing them. These compounds are particularly useful in the treatment or prophylaxis of cardiovascular disorders such as heart failure and coronary artery disease.

Career Highlights

Petra Johannesson is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to focus on innovative solutions for complex health issues, particularly in the cardiovascular domain.

Collaborations

Throughout her career, Petra has collaborated with notable colleagues, including Tord Bertil Inghardt and Ulrik Jurva. These collaborations have contributed to the advancement of her research and the successful development of her patented compounds.

Conclusion

Petra Johannesson's contributions to the field of cardiovascular therapy through her innovative patents highlight her role as a key inventor in the pharmaceutical industry. Her work continues to pave the way for new treatments that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…